Cargando…
Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?
Historically, randomized controlled trials (RCTs) have shown an increased risk of recurrence and mortality among women who have used primarily oral HRT after breast cancer. However, many of these studies have had design flaws that may impact the findings. Numerous investigators have concluded that a...
Autores principales: | Lupo, Molly, Dains, Joyce E., Madsen, Lydia T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677805/ https://www.ncbi.nlm.nih.gov/pubmed/26705493 |
Ejemplares similares
-
Clinical Management of Bowel Dysfunction After Low Anterior Resection for Rectal Cancer
por: Bazzell, Angela, et al.
Publicado: (2016) -
Instruments That Predict Oncology Treatment Risk in the Senior Population
por: Schiefen, Jessica K., et al.
Publicado: (2017) -
Effectiveness of Granulocyte Transfusions in Neutropenic Adult Oncology Patients: A Comprehensive Review of the Literature
por: Demla, Asha, et al.
Publicado: (2016) -
The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma
por: Pachella, Laura A., et al.
Publicado: (2015) -
The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan
por: Liu, Jui-Yao, et al.
Publicado: (2016)